Interestingly, clinical studies indicate that the expansion of dnT cells as well as the CD62L- CD197- effector-memory T cells and the CD62L+CD197+ central-memory cells are controlled by mTOR since rapamycin treatment decreased these populations in SLE patients (31, 32). This evidence concerns the gene SELL and systemic lupus erythematosus.